In addition, MMF treatment induced myeloid differentiation, as indicated by the increased expression of CD11b, CD14, CD33, and CD66b, predominately in AML cell lines with MLL fusions (Fig. 3m and Supplementary Fig. 3u, v). The gene discussed is CEACAM8; the disease is acute myeloid leukemia.